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ABSTRACT 32 
Our objective was to determine the effects of a polyphenol-enriched cocoa extract (PCE) on myocardial 33 
postischemic alterations in normotensive (Wistar rats, W) and spontaneously hypertensive rats (SHR). 34 
Isolated hearts were submitted to 110 min of perfusion or 20-min stabilization, 30-min global ischemia 35 
and 60-min reperfusion (R). Other hearts were treated with PCE at the onset of R. Infarct size, the 36 
reduced glutathione (GSH) and the expression of phospho-Akt, P-GSK-3β and P-eNOS were assessed. In 37 
isolated mitochondria the Ca
2+
- mediated response of mitochondrial permeability transition pore (mPTP), 38 
membrane potential (∆ψm) and superoxide production were determined. PCE decreased infarct size, 39 
partly preserved GSH, increased the P-Akt, P-GSK-3β and P-eNOS contents, improved mPTP response 40 
to Ca2+, decreased the superoxide production and restored ∆ψm.  41 
These data show that PCE decreases the cardiac postischemic damage in W rats and SHR and suggest that 42 
Akt/GSK-3β/eNOS dependent pathways are involved. 43 
 44 
Key words: Wistar, SHR, infarct size, mitochondria, polyphenols 45 
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INTRODUCTION 47 
Cocoa and chocolate are two products derived from processing of cocoa beans. This complex multistage 48 
process begins with spontaneous fermentation driven in the postharvest period by different 49 
microorganisms derived from the environment 
1
. After fermentation cocoa beans are roasted, shelled, and 50 
ground. The main difference between cocoa and chocolate is the absence or existence of cocoa butter. In 51 
cocoa, butter is little or non-existent. In contrast, chocolate has butter. Therefore, cocoa is considered as a 52 
healthy drink because it has less sugar and fat and besides possesses an important amount of flavanols 
2
, 53 
being catechins and epicatechins the main 
3, 4
.  There are many evidences regarding the beneficial actions 54 
of chocolate and cocoa on immune functions, ageing, blood pressure regulation, atherosclerosis, insulin 55 
resistance, physical performance or cardiovascular diseases development. However, the molecular 56 
mechanisms remain under investigation and the subject of ongoing discussion 
5-9
.  57 
The ischemic heart disease is an important cause of death worldwide 
10
, being the high blood pressure an 58 
important risk factor. Although the reperfusion reduces the mortality, it introduces an additional injury. 59 
Thus, many studies demonstrate that drugs or strategies applied at the beginning of reperfusion are able to 60 
reduce infarct size 
11-14
. It has also been previously showed that hypertrophy consequent to chronically 61 
elevated blood pressure aggravates the reperfusion injury 
15, 16
. 62 
Mitochondrial integrity is critical in the maintenance of bioenergetics and Ca
2+
 homeostasis of the 63 
myocardium. Upon reperfusion the mitochondrial Ca
2+ 
overload leads to myocyte death by multiple 64 
mechanisms including oxidative injury and opening of the mitochondrial permeability transition pore 65 
(mPTP) 
10
.  Therefore, the inhibition of mPTP at the beginning of reperfusion may prevent cell death and 66 
thus reduce infarct size 
17-19
. 67 
Epidemiological evidences indicate that the consumption of flavonoids-rich foods or beverages decreases 68 
the incidence of cardiovascular disease 
20-22
. Different studies showed the benefits of cocoa on the 69 
prevention of CVD, the ability to modulate the blood pressure in hypertensive animals and the capacity to 70 
improve coronary circulation in healthy adults 
23-27
. Recently, Cienfuegos-Jovellanos et al. 
28
 developed a 71 
cocoa powder with the highest flavonoid monomer content. The antihypertensive effect exerted by that 72 
cocoa powder (PCE) has been previously demonstrated by the same authors 
29
. However, its action during 73 
ischemia-reperfusion is still unknown.  74 
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The purpose of this study was to examine the actions of ¨ex vivo¨ treatment with PCE, administered at the 75 
beginning of reperfusion, on infarct size and mitochondrial state in hearts from normotensive and 76 
spontaneously hypertensive rats submitted to ischemia-reperfusion. 77 
 78 
 79 
 80 
  81 
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MATERIAL AND METHODS 82 
Animals  83 
Male SHR and W rats were used. The animals were housed 4 per cage, with food and drinking water ¨ad 84 
libitum¨. The room ventilation rate was 4-6 changes per h, at temperature of 22 ± 2 °C and with a light 85 
cycle/dark of 12 h. All procedures followed during this investigation were approved by the Institutional 86 
Animal Care and Use Committee (IACUC) of the Faculty of Medicine, University of La Plata (P-05-87 
2014). 88 
Systolic blood pressure measurement 89 
Systolic blood pressure (SBP) was measured in alive and awake animals by a modified tail-cuff method 90 
30
. 91 
Polyphenol-Enriched Cocoa Extract (PCE) 92 
The preparation, characteristics and composition of PCE are described in a previous paper 
31
. Briefly, 93 
PCE was obtained from CocoanOX 
32
 and produced from unfermented, blanch-treated, and roasted cocoa 94 
beans. By HPLC, the total polyphenol content was 547 ± 4 mg/dry matter being the 50% represented by 95 
the total flavan-3-ol content followed by (-)-epicatechin (26%) and procyanidin B2 (15%). 96 
Isolated heart preparation 97 
Rats were anesthethized with ketamine-diazepam (80-5 mg/Kg). Arreflexia appearance with loss of 98 
corneal reflex and the flexor reflex of escape in the lower limbs were verified before heart isolation.  99 
Isolated hearts were perfused following the instructions previously detailed 
13
. 100 
Experimental protocols 101 
After 20-min stabilization, the following experimental protocols were performed: Non-ischemic control 102 
hearts (NIC; n = 5 for each rat strain): hearts were perfused for 90 min without any treatment. Ischemic 103 
control hearts (IC, n = 7 for each rat strain): hearts were subjected to 30 min of global ischemia followed 104 
by 60 min of reperfusion. PCE (n = 7 for each rat strain): hearts were treated during 10 min at the onset of 105 
reperfusion with PCE (30 µg/mL). Other hearts (n = 4 for each rat strain and for each protocol) were used 106 
for biochemical determinations and others (n = 4 for each protocol and for each rat strain) for 107 
mitochondria isolation. 108 
Infarct size determination 109 
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Infarct size was assessed by the triphenyltetrazolium chloride (TTC, Sigma-Aldrich, Munich, Germany) 110 
staining technique. At the end of reperfusion hearts were frozen, cut into six transverse slices and 111 
incubated in TTC. Infarct size was expressed as a percentage of total area (area at risk) 
33
.   112 
Lipid peroxidation  113 
A portion of left ventricle (LV) was homogenized and centrifuged at 3000 rpm.  In the supernatant, the 114 
concentration of thiobarbituric acid reactive substances (TBARS) was measured and expressed in 115 
nmol/mg of protein 
34
. 116 
Reduced glutathione (GSH) 117 
GSH content was determined in the supernatant using the Ellman´s reagent 
35
 and expressed as µg/mg of 118 
protein. 119 
Immunoblotting  120 
Other portion of LV was homogenized and cytosolic fraction was isolated by differential centrifugation. 121 
Briefly, supernatant proteins were resolved on SDS-PAGE, transferred to PVDF membrane, blocked and 122 
probed with antibodies against phosphorylated forms of GSK-3β-Ser9, Akt, eNOS-Ser1177, anti-MnSOD 123 
and anti-Cytochrome c. Protein bands were analyzed by a chemiluminescent system and total GSK-3β, 124 
Akt and eNOS content or GAPDH signal were used as a loading control 
13
. 125 
Isolation of mitochondria 126 
LV of other sets of control and treated hearts from W rats and SHR were used to mitochondria isolation 127 
following the method previously described 
13
. 128 
Ca
2+
- induced mPTP opening  129 
The isolated mitochondria were energized and induced to swell with the addition of CaCl2. If mPTP 130 
opens the mitochondria swells. These changes are observed as decreases of light scattering (LSD) at 520 131 
nm using a temperature-controlled Hitachi F4500 spectrofluorometer 
36
. LSD was assessed in samples 132 
without any treatment and in those treated with PCE 10 µg/ml. 133 
Mitochondrial membrane potential 134 
Mitochondrial potential (∆Ψm) was evaluated by measuring rhodamine-123 (RH-123) fluorescence 135 
quenching 
37
 and calculated following the instructions previously detailed 
38
.  136 
Measurements of O2
-.
  production 137 
Superoxide production was measured in intact mitochondria suspension with lucigenin-enhanced 138 
chemiluminiscence (CL) as previously described 
39
. The CL in arbitrary units (a.u.) was recorded with a 139 
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luminometer (Chameleon, Hidex, Tuku, Finland) for 10 sec each one with 1 min interval during 10 min in 140 
the presence or absence of succinate (6 mM/L) or PCE (10 µg/ml). Mitochondrial O2
-. 
production was 141 
expressed as a.u./min/mg protein.  142 
Statistical analysis 143 
Data were expressed as means ± SE. Differences between groups were assessed with a two-way analysis 144 
of variance (ANOVA) test and Newman-Keul’s was used as a post hoc test. A value of p < 0.05 was 145 
considered to be statistically significant. 146 
  147 
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RESULTS 148 
Mean data of systolic blood pressure (SBP) plus the values of body weight (BW, g), left ventricular 149 
weight (LVW, mg) and hypertrophic index (HI, calculated as LVW and BW ratio) of W rats and SHR are 150 
displayed in Table 1. SBP, LVW and HI were significantly higher in SHR than W rats, indicating the 151 
presence of hypertrophy associated to high pressure as one recognized characteristic of hypertensive 152 
animals.  153 
Infarct size 154 
Hearts from W rats and SHR without any treatment caused an infarct size of ~30% of the risk area. When 155 
PCE was added to the perfusate a significant reduction in infarct size was obtained (Fig. 1).  156 
TBARS and GSH  157 
The TBARS concentration- as an index of lipid peroxidation- of IC hearts was 0.75 ± 0.06 and 0.97 ± 158 
0.10 nmol/mg protein for W rats and SHR, respectively. These values were not significantly modified by 159 
PCE treatment (0.61 ± 0.08 and 0.70 ± 0.15 nmol/mg protein for W rats and SHR, respectively).  The 160 
GSH content in non-ischemic control hearts from SHR was lower than that detected in hearts from W 161 
rats. After ischemia-reperfusion, GSH levels decreased to a similar value in hearts from SHR and W rats. 162 
The treatment with PCE partially or fully preserved the GSH content in hearts from normotensive and 163 
hypertensive rats, respectively (Fig. 2). 164 
Expression of P-Akt, P-GSK-3β and P-eNOS 165 
At the end of reperfusion period, homogenates of PCE treated hearts from W rats and SHR showed a 166 
significant increase of the expression of phosphorylated forms of Akt, e-NOS and GSK-3β (Fig. 3).  167 
MnSOD and cytochrome c 168 
The loss of internal mitochondrial membrane impermeability leads to the release of mitochondrial matrix 169 
components, as MnSOD and cytochrome c, to cytosol. Thus, the expression of both substances increased 170 
in ischemic control hearts from W rats and SHR and decreased in PCE treated hearts from both rats 171 
strains (Fig. 4). 172 
Ca
2+
- induced mPTP opening (LSD) and mitochondrial membrane potential (∆Ψm) 173 
Figure 5 shows the typical traces (A panel) and mean values (B panel) of light scattering decrease (LSD) 174 
produced by the addition of 100 µmol/L Ca
2+
 to mitochondrial suspensions of untreated and treated hearts 175 
from W rats and SHR. LSD was significantly lesser  in non-ischemic hearts from SHR in comparison to 176 
those of W rats. After ischemia-reperfusion, the LSD decreased to a similar value for hearts from both 177 
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rats strains. The treatment with PCE improved the response of mitochondria to Ca
2+
 showing greater LSD 178 
values than ischemic hearts but lesser than those observed in non-ischemic hearts. Figure 6 shows the 179 
changes of ∆ψm in the three experimental protocols. The ∆ψm of mitochondria isolated from SHR hearts 180 
was significantly lesser than those of W rats. After ischemia-reperfusion the ∆ψm decreased in both rats 181 
strains. The treatment with PCE attenuated this depolarization reaching ∆ψm values not statistically 182 
different to those obtained in non-ischemic control hearts but maintaining the difference between W rats 183 
and SHR. 184 
Mitochondrial O2
-. 
 production 185 
As shown in Figure 7 the incubation of cardiac mitochondria with lucigenin elicited a basal O2
-. 
186 
production in W and SHR. This response appears to be due to the presence of endogenous substrates in 187 
the freshly isolated mitochondria. The addition of succinate significantly enhanced the O2
-.  
production in 188 
mitochondria from both rats strains and decreased after treatment with PCE.  189 
  190 
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DISCUSSION 191 
The present data showed that the ¨ex vivo¨ treatment at the onset of reperfusion with a polyphenol-192 
enriched cocoa extract (PCE) decreased the cell death and attenuated the mitochondrial injury produced 193 
by ischemia-reperfusion in hearts from normotensive and spontaneously hypertensive rats.  194 
Hypertension is an important cause of cardiovascular morbidity and mortality and it has been associated 195 
with impaired antioxidant defense and specially with disturbances in glutathione metabolism 
40, 41
. This 196 
was evident in our study since we found lesser GSH values in non-ischemic control hearts from SHR in 197 
comparison to W rats. The treatment with PCE partially or fully preserved the level of GSH in hearts 198 
from W rats and SHR, respectively. Additionally, a decreased O2
-. 
production in isolated mitochondria 199 
from PCE-treated hearts of both rats strains was showed. These results suggest that a reduced ROS 200 
production and/or higher scavenging could be taking place in cardiac tissue from normotensive and 201 
hypertensive animals when they were submitted to ischemia and reperfusion in presence of PCE.  202 
On the other hand, and in agreement with a recent paper published by us 
42
, the ∆Ψm of mitochondria 203 
isolated from SHR hearts was less electronegative than that detected in hearts from W rats. After ischemia 204 
and reperfusion, the mitochondria suffered depolarization, reaching a similar ∆Ψm in both rats strains. 205 
The treatment with PCE normalized ∆Ψm, maintaining the difference between W rats and SHR.  206 
The mitochondrial permeability transition pore (mPTP) plays a critical role in determination of cell death 207 
and is the focal point of the various protective mechanisms 43-45. The mPTP opening leads to matrix 208 
swelling and efflux of cyc and other proapoptotic factors 
46, 47
. Our data show that the Ca
2+
- mediated 209 
response of mitochondria isolated from non-ischemic control hearts of W rats was higher than those of 210 
SHR, diminished to a similar value when hearts were submitted to ischemia-reperfusion and was partially 211 
restored in PCE treated hearts. Therefore, the restoration of ∆Ψm and the Ca
2+
 response are indicators of 212 
an improvement of mitochondrial state mediated by PCE. In our conditions, we also detected an increase 213 
of MnSOD and cyc expression in ischemic control hearts from W rats and SHR which decreased after 214 
PCE treatment. All these data are evidence of the protective role of cocoa extract against mitochondria 215 
permeability and suggest that an attenuation of ROS production and a diminution of Ca
2+
 uptake by 216 
mitochondria could be the responsible mechanisms. 217 
A relevant piece of information is how processes occurring in the cytosol modulate mPTP opening. 218 
Which are the PCE targets?. GSK-3β phosphorylation is a step to which multiple protective signaling 219 
pathways converge ending to avoid the mPTP opening 
48
. In our experimental conditions, the treatment 220 
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with PCE increased the level of phospho-GSK-3β in both rats strains suggesting that the PCE-mediated 221 
cardioprotection is linked to GSK-3β-dependent mechanism. Among the kinases able to activate GSK-3β 222 
is the PI3K/Akt which has been involved in the beneficial actions during ischemia-reperfusion 
49
. We also 223 
observed a decrease of phospho- Akt level whereas opposite changes took place in PCE treated hearts.  224 
Several papers have demonstrated the protective role of NO during ischemia-reperfusion 
50, 51
. It is 225 
recognized that the balance of NO concentration depends of its production by increase of eNOS 226 
expression and/or activity and the O2
-.
 formation in which the eNOS uncoupling plays an important role 227 
52
.  In our experimental conditions, PCE increased the expression of phosphoSer1177-eNOS, which 228 
linked to the reduced O2
-.
  production could lead to a higher NO bioavailability in PCE-treated compared 229 
to untreated hearts. Therefore, the data present herein show, by the first time, that NO could be an 230 
important mediator of the infarct size limitation afforded by PCE.  231 
PCE contains four times more procyanidins and eight times more epicatechin and procyanidin B2 than 232 
conventional cocoa powder 
31
. There is accumulating evidence that (−)-epicatechin and its derivatives 233 
have significant role in prevention of CVD in humans 
53
. Potent antioxidant action, modulation of cell 234 
signalling, reduction of the blood pressure, and protection of mitochondria, are being proposed as possible 235 
mechanisms of beneficial effects of (−)-epicatechin 
54
. The ability of (−)-epicatechin to prevent oxidative 236 
stress by restoring NO bioavailability was has been also showed 
55
. Recently, it was demonstrated that 237 
(−)-epicatechin and procyanidin B2 improve mitochondrial functions detecting a decrease of cyc release 238 
56
. As these compounds are present in high proportion in PCE, it might be responsible for the beneficial 239 
effects detected in PCE-treated hearts. 240 
In summary, our findings show that the ¨ex vivo¨ treatment of PCE at the onset of reperfusion ameliorates 241 
the infarct size in hearts from W rats and SHR by attenuation of mPTP opening and suggest that 242 
Akt/eNOS and Akt/GSK-3β-dependent signaling pathways are involved. Thus, our data are providing 243 
arguments to establish the benefits of PCE against the mitochondrial impairment produced by ischemia-244 
reperfusion. A decrease of ROS production by mitochondria plus to the scavenging activity of the extract 245 
which leads to the preservation of GSH levels could be contributing to the cardioprotective action (Fig. 246 
8). 247 
Limitations 248 
In the current study we demonstrated, by the first time, in a model of heart ¨ex vivo¨ the beneficial action 249 
of a polyphenol-enriched cocoa extract against reperfusion injury. However, the complex composition of 250 
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the extract and the low intestinal absorption of its constituents determine that our findings could not be 251 
extrapolled directly to human. Furthermore, long-term trials will be needed to investigate the incidence of 252 
PCE addition to diet on clinical outcomes of patients suffering adverse cardiovascular events.  253 
 254 
ABBREVIATIONS 255 
 256 
Cyc: Cytochrome c 257 
eNOS: Endothelial nitric oxide synthase  258 
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase  259 
GSK-3β: Glycogen synthase kinase-3 beta 260 
IC: Ischemic control hearts 261 
MnSOD: Manganese-dependent superoxide dismutase  262 
mPTP: Mitochondrial permeability transition pore 263 
∆Ψm: Mitochondrial potential 264 
NIC: Non-ischemic hearts 265 
W: Normotensive Wistar rats 266 
PCE: Polyphenol-enriched cocoa extract 267 
ROS: Radical oxygen species 268 
GSH: Reduced glutathione  269 
Akt: Serine/threonine-specific protein kinase 270 
SHR: Spontaneously hypertensive rats 271 
O2
-. 
: Superoxide anion 272 
TBARS: Thiobarbituric acid reactive substances  273 
TTC: Triphenyltetrazolium chloride 274 
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Legends 431 
Figure 1: A panel: Scheme of ischemic control (IC) and polyphenol-enriched cocoa extract (PCE) 432 
protocols and representative slices of hearts from normotensive (W) and spontaneously hypertensive rats 433 
(SHR) stained with TTC. B panel: Mean values of infarct size (IS), expressed as a percentage of risk area, 434 
in IC (n = 7) and PCE (n = 7) treated hearts from W rats (n = 14) and SHR (n = 14). Observe that the 435 
treatment with PCE decreased the IS detected in IC hearts of both rats strains. * p < 0.05 vs. IC 436 
Figure 2: Reduced glutathione content (GSH, µg/mg protein) in non-ischemic control (NIC, n = 4), 437 
ischemic control (IC, n = 4) and PCE (n = 4) treated hearts from normotensive (W, n = 12) and 438 
spontaneously hypertensive rats (SHR, n = 12). The GSH content diminished in IC and it was partially or 439 
fully preserved in W rats and SHR, respectively, in PCE treated hearts . φ p < 0.05 SHR vs. W; * p< 0.05 440 
vs. NIC; # p < 0.05 vs. IC. 441 
Figure 3: Representative immunoblots of total and phosphorylated forms and summary of densitometry 442 
data of phospho-Akt (A panel), phospho-eNOS (B panel) and phospho- GSK-3β (C panel) in non-443 
ischemic control (NIC, n = 4), ischemic control (IC, n = 4) and PCE (n = 4) treated hearts from W rats ( n 444 
= 12) and SHR (n = 12). The P-Akt/Akt, P-eNOS/eNOS and P-GSK-3β/ GSK-3β ratios diminished in IC 445 
and increased in PCE treated hearts of both rats strains. * p< 0.05 vs. NIC; # p< 0.05 vs. IC. 446 
Figure 4: Expression of MnSOD (A panel) and cytochrome c (cyc, B panel) in non-ischemic control 447 
(NIC, n = 4), ischemic control (IC, n = 4) and PCE (n = 4) treated hearts from W rats (n = 12) and SHR (n 448 
= 12). Note that a significant increase of MnSOD and cyc was detected in IC hearts from both rats strains 449 
which returned to basal values by PCE treatment. * p < 0.05 vs. NIC; # p < 0.05 vs. IC. 450 
Figure 5: A panel: Typical traces produced by 100 µM Ca2+ addition to samples of mitochondria from W 451 
rats and SHR hearts. B panel: Mean values of the light scattering decreases (LSD) after Ca
2+
 addition, 452 
expressed in arbitrary units (a.u.), in non-ischemic control (NIC, n = 4), ischemic control (IC, n = 4), and 453 
PCE (n = 4) treated hearts from W rats (n = 12) and SHR (n = 12). The response of isolated mitochondria 454 
to Ca2+ significantly diminished in IC hearts and partially recovered after PCE treatment in both rats 455 
strains. φ p < 0.05 SHR vs. W; * p < 0.05 vs. NIC; # p < 0.05 vs. IC. 456 
Figure 6: Mitochondrial membrane potential (∆Ψm, mV) measured in isolated mitochondria from 457 
normotensive (W, n = 12) and spontaneously hypertensive rats (SHR, n = 12) hearts of non-ischemic 458 
control (NIC, n = 4), ischemic control (IC, n = 4) and PCE treated group (n = 4). The depolarization 459 
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detected after ischemia and reperfusion was attenuated in PCE treated hearts.  φ p < 0.05 SHR vs. W; * p 460 
< 0.05 vs. NIC; # p < 0.05 vs. IC. 461 
Figure 7: A and C panels: Time course of O2
-. production of cardiac mitochondria isolated from W rats 462 
and SHR, in presence or absence (C, n = 3 for W and n= 3 for SHR) of succinate (S, n = 3 for each rat 463 
strain ) or S + PCE (n = 3 for each rat strain). The chemiluminiscence response was initiated by adding of 464 
lucigenin. B and D panels: Mean values of O2
-.  
production at 3 min in C, S and S + PCE mitochondrial 465 
suspensions of W rats and SHR. PCE decreased the O2
-.  production in both rats strains. * p < 0.05 vs.  C; 466 
# p < 0.05 vs. PCE.  467 
Figure 8: Scheme showing the signaling pathways that involve activation of kinases and enzyme leading 468 
to the polyphenol-enriched cocoa extract (PCE)-mediated cardioprotection highlighting the mitochondrial 469 
effects.   470 
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 471 
 472 
Table 1: Data of systolic blood pressure (SBP), body weight (BW), left ventricular 473 
weight (LVW) and hypertrophy index (IH) in W and SHR 474 
 475 
 W SHR 
SBP (mmHg) 125 ± 2 219 ± 3** 
BW (g) 309 ± 9 310 ± 8 
LVW (mg) 780 ± 40 1330 ± 60** 
HI 2.52 ± 0.12        4.17 ±0.18** 
 476 
**p < 0.01   n = 30 for each one  477 
 478 
479 
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FIGURE 1 480 
   481 
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FIGURE 5 487 
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FIGURE 6 489 
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FIGURE 7 491 
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FIGURE 8 493 
 494 
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